CAS 476148-82-0

Thieno[2,3-d]pyrimidine, 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)-, hydrochloride, hydrate (1:1:1)

Description:

Thieno[2,3-d]pyrimidine, 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)-, hydrochloride, hydrate (1:1:1) is a chemical compound characterized by its complex structure, which includes a thieno[2,3-d]pyrimidine core fused with a 2-fluorophenyl group and a piperazine moiety. This compound is typically encountered as a hydrochloride salt, which enhances its solubility in aqueous environments, making it suitable for pharmaceutical applications. The presence of the fluorophenyl group may influence its biological activity and pharmacokinetics, while the piperazine ring is often associated with various pharmacological properties, including anxiolytic and antidepressant effects. The hydrate form indicates that the compound can associate with water molecules, which can affect its stability and solubility. Overall, this compound is of interest in medicinal chemistry, particularly for its potential therapeutic applications, and its unique structural features contribute to its biological activity. As with many pharmaceuticals, understanding its characteristics is crucial for optimizing its use in drug development and therapeutic contexts.

Formula: C₁₇H₂₀ClFN₄OS

Synonyms:

• AA-10025
• AA10021
• MCI-225 hydrochloride hydrate
• DDP-225
• AA-10021
• MCI 225 hydrochloride hydrate,MCI225 hydrochloride hydrate
• AA-10026
• Thieno[2,3-d]pyrimidine, 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)-, hydrochloride, hydrate (1:1:1)

MCI-225 hydrochloride hydrate

CAS: 476148-82-0

MCI-225, a combined NE and 5-HT reuptake inhibitor, may treat Alzheimer's by improving attention and brain metabolism.

Formula: C₁₇H₂₀ClFN₄OS

Purity: 98%

Color and Shape: Solid

Molecular weight: 382.88

Ref: TM-T8443L